We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IFF:NYSEInternational Flavors & Fragrances, Inc. Analysis

Data as of 2026-09-11 - not real-time

$83.70

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

International Flavors & Fragrances Inc. trades at $83.70, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. The last 30 days have gained 5.3%. Momentum indicators put RSI at 47.6 (neutral) with MACD reading bearish. Recent trading has carved out support near $80.87 and resistance around $88.64.
On valuation the read is fair — an earnings multiple of 21.1, absent a reliable peer benchmark. Consensus targets land 14.3% above where the shares trade now. The 1.90% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 33.8%, a beta of 0.73 and a maximum drawdown of 19.7%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 2/10 conviction on the long call.

Top Market Events

IFF delivers 6% sales growth across all segments, announces $2.Wrapping up Q1 earnings, we look at the numbers and key takeaways for the ingredients, flavors & fragrances stocks,...International Flavors & Fragrances IFF released second quarter 2026 results that combined higher sales with sharply...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 75.02
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 75.02
  • Analyst targets imply +14.3% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply +14.3% versus the current price
  • Negative return on equity of -5.5%
  • Negative free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth1.80%
Profit Margin2.57%
P/E Ratio21.1
ROE-5.55%
ROA2.27%
Debt/Equity44.82
P/B Ratio1.5
Op. Cash Flow$1.2B
Free Cash Flow$-1720999936

Technical Analysis

TrendBullish
RSI47.6
Support$80.87
Resistance$88.64
MA 20$85.12
MA 50$81.98
MA 200$75.02
MACDBearish
VolumeIncreasing
Fear & Greed Index93.36

Valuation

Fair Value$20.85
Target Price$95.66
Upside/Downside14.28%
GradeFair
TypeBlend
Dividend Yield1.90%

Risk Assessment

Beta0.73
Volatility33.80%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.